Sativa Wellness Group Announces Name Change and Strategic Update

News and research before you hear about it on CNBC et al. Claim your 1-week free trial for Street Insider Premium here.

VANCOUVER, BC / ACCESSWIRE / January 9, 2022 / Sativa Wellness Group Inc. (CSE: SWEL) (“Sativa Wellness” or the “Company”) is pleased to announce a name change to Goodbody Health Inc to align the parent company with its main brand “Goodbody” and its affiliates commercial “Goodbody Wellness Limited” and “Goodbody Botanicals Ltd”. After extensive feedback, the Board of Directors decided that the Goodbody brand using the “Learn More – Live Better” proposition further promotes and reflects the strategic direction of the company as a health and wellness company. well-being.

The Company name change will be updated as of 8:00 am on January 13, 2022 UK time on the Apex segment of the AQSE Growth Market (“AQSE”) and on the Canadian Stock Exchange (“CSE ») As soon as the market opens. The shares of the Company will begin to trade under the new ticker “GBDY” on these exchanges from the same hours.

The over-the-counter (“OTC”) market in the United States and the Frankfurt Stock Exchange (“FSE”) are expected to reflect this change shortly thereafter on their existing tickers as “484” for the FSE and “SCNFF” for the OTC. .

The Company’s web address will change effective January 12, 2022 to become

In 2020, the company set up COVID testing clinics for travelers in response to the pandemic to complement the existing wellness activity. The success of these clinics continues to evolve into a range of wellness testing products and services in addition to COVID testing and CBD products, with the realization that clients seek wellness management as well as ‘a diagnosis of symptoms. This has resulted in strong sales growth through local independent pharmacies who are proactive in helping their community as well as directly to businesses and individuals.

The need for radical investment and reform of diagnostic services was recognized as the NHS long-term plan was released in 2019. The Covid-19 pandemic has further amplified the need for change radical in providing diagnostic services.

Currently, we have a local network of over 140 clinics across the country, offering over 30 blood and PCR tests for home and / or clinic testing. We continue to provide CBD wellness products which all go through FSA as part of the novel food process as well as cannabinoid testing. By the end of 2022, we aim to offer 1,000 customer service points as well as a wider range of products and services.

Geremy Thomas, Executive Chairman, said: “Following the tremendous successes of 2021 in delivering health and wellness products and services, we are extremely keen to ensure that all of our investors and other stakeholders understand the strategic direction of the business. The repositioning of our brand as Goodbody Health, combined with our key customer proposition of Know More – Live Better “better reflects our mission to be a leading provider of wellness products through our ever expanding distribution channels. We are very positive about the opportunities this will bring in 2022 and beyond. “

The Directors of the Company accept responsibility for the content of this announcement.

On behalf of the Board of Directors,

Marc Howells
Chief executive officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
[email protected]

Anne Tew
Financial director
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
[email protected]

Neither the Canadian Securities Exchange nor its market regulator (as defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities laws and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of US Private Securities Litigation. Reform Act. of 1995. These forward-looking information and forward-looking statements are not representative of historical facts or information or the current state of affairs, but only represent the Company’s beliefs regarding future events, plans or objectives, many of which by their nature, are inherently uncertain and beyond the control of Sativa. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terms such as “plans”, “expects” or “does not expect”, “is expected”, “budget” , “Planned”, “estimates”, “plans”, “intends”, “anticipates” or “does not anticipate”, or “thinks” “is” the plan is “or variations of these words and expressions or may contain statements that certain actions, events or results “may”, “could”, “would”, “could” or “will be taken”, “will continue”, “will take place”, “will be achieved” or “under little “. Forward-looking information and forward-looking statements contained in this document include, without limitation, the name change of the Company which will be updated from 8:00 a.m. on January 13, 2022 UK time in the segment AQSE Growth Market Apex (“AQSE”) and the Company’s shares will trade under the new ticker “GBDY” from the same period. The Canadian Securities Exchange (“CSE”), the over-the-counter (“OTC”) market in the United States and the Frankfurt Stock Exchange (“FSE”) are expected to reflect this change shortly thereafter.

The new ticker for CSE and AQSE will be “GBDY” while FSE will remain as “484” and OTC as “SCNFF”.

Although Sativa believes that the assumptions and factors used in the preparation, and the expectations contained in, the forward-looking information and statements are reasonable, such information and statements should not be trusted unduly, and no assurances or guarantees can be made. given that these forward-looking information and statements prove to be correct, as actual results and future events could differ materially from those anticipated in such information and statements. Forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and include, without limitation, that by the end of 2022, the Company aims to offer 1,000 points. of service for customers as well as a wider range of products and services.

Sativa does not undertake to update any forward-looking information and / or forward-looking statements contained or referenced herein, except in accordance with applicable securities laws.

THE SOURCE: Sativa Wellness Group Inc.

See the source version on

Source link

About Michael S. Montanez

Check Also

MIMEDX GROUP, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations (Form 10-Q)

Insight MIMEDX is a transformational placental biologics company, developing and distributing placental tissue allografts with …